Copyright
©The Author(s) 2025.
World J Transplant. Sep 18, 2025; 15(3): 103958
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.103958
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.103958
Table 1 Innovations in fertility preservation and pregnancy management for transplant patients, along with their successes and limitations/challenges
Innovation | Successes | Limitations/challenges | Ref. |
Oocyte cryopreservation | Successful long-term storage of oocytes before transplant procedures | Potential risk of ovarian failure due to immunosuppressive therapy | [17] |
Offers female transplant patients the possibility of future fertility options | Limited knowledge of the effects of cryopreservation on oocyte quality post-transplant | ||
Embryo cryopreservation | High success rates of pregnancy post-transplant when embryos are used after fertilization | Ethical concerns and challenges with donor sperm/eggs | |
Suitable for patients undergoing fertility treatment before transplantation | Requires hormonal stimulation, which may not be possible for all transplant patients due to their medical conditions | ||
Testicular tissue cryopreservation | Success in preserving fertility in male transplant patients | Limited access and expertise in cryopreservation of testicular tissue | |
Potential to preserve the ability for future sperm retrieval even after the transplant | Uncertainty of long-term success in fertility restoration | ||
IVF | Allows transplant patients to use their gametes or preserved embryos to conceive | IVF may not be feasible for all patients due to immunosuppressive therapy or health complications | |
Hormonal manipulation during pregnancy | Modifies immunosuppressive therapy to reduce risks during pregnancy, leading to successful pregnancies | Risk of graft rejection or complications in maintaining immune balance | |
Tailored immunosuppression protocols can enhance pregnancy outcomes for transplant patients | Hormonal therapies can have side effects that complicate pregnancy | ||
Genetic counseling | Helps patients understand the risks of inherited diseases or the effects of transplantation on offspring | Limited access to specialized genetic counseling in some regions | |
Provides a clear understanding of pregnancy and fertility options for transplant patients | Emotional and psychological challenges for patients in dealing with possible outcomes | ||
Pre-implantation genetic testing | Identifies genetic disorders in embryos, reducing the risk of inherited conditions in offspring | High cost and limited availability of testing | |
Helps to choose the healthiest embryos, which is crucial in transplant patients with compromised health | Ethical concerns surrounding genetic screening and selection | ||
Pregnancy monitoring post-transplant | Advanced monitoring technologies help track graft function and fetal development simultaneously | The increased complexity of monitoring, especially in immunosuppressed patients, may increase medical burden | |
Early intervention and personalized care plans can improve pregnancy outcomes for transplant patients | Risk of complications, including organ rejection and infection, remains a challenge |
- Citation: Lazarov V, Naseva E, Miteva DG, Tomov LP, Shumnalieva R, Peruhova M, Velikova T. Advances in fertility preservation and pregnancy care for transplant patients. World J Transplant 2025; 15(3): 103958
- URL: https://www.wjgnet.com/2220-3230/full/v15/i3/103958.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i3.103958